82
Participants
Start Date
July 1, 2014
Primary Completion Date
August 31, 2020
Study Completion Date
August 31, 2020
Dextroamphetamine
Each participant receives a single pill of placebo or active drug (dextroamphetamine 10 mg) and completes approximately 6 hours of testing in the laboratory. One week later, that participant receives a single pill of the alternate comparator and is again tested in the laboratory. Thus, in total, each participant receives one placebo pill and one active pill, separated by one week.
Placebo
Each participant receives a single pill of placebo or active drug (dextroamphetamine 10 mg) and completes approximately 6 hours of testing in the laboratory. One week later, that participant receives a single pill of the alternate comparator and is again tested in the laboratory. Thus, in total, each participant receives one placebo pill and one active pill, separated by one week.
Clinical Teaching Facility (CTF-B102) at UCSD Medical Center, San Diego
University of California, San Diego
OTHER